Improving outcomes for children and teenagers with brain cancer will be the focus of Australia’s first research centre aimed solely at tackling the cancer in young people.
Researchers will soon understand how to better target cancer treatments with the opening of a new Australian Cancer Research Foundation (ACRF) facility at The University of Queensland (UQ).
The Director of The University of Queensland’s Institute for Molecular Bioscience (IMB) will help steer a national initiative striving to double survival rates for people with brain cancer over the next decade.
Cancer biologist Dr Laura Genovesi is the recipient of a 2017 Early Career Fellowship to progress vital research into medulloblastoma, the most common type of malignant childhood brain cancer.
An international team of researchers has found a drug previously approved to treat breast cancer could also be used to shrink medulloblastoma, a common form of childhood brain tumour.
IMB researchers have found a promising small molecule treatment that blocked cancer spread and improved survival rates in mice in a pre-clinical study of breast cancer.